Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.0
87.01%
60%
—
-42.77%
40%
—
5 Years
Score5.0
Net Growth87.01%
Net Trend60%
Net Income Consistency—
Rev Growth-42.77%
Rev Trend40%
Revenue Consistency—
Cyclerion Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 2M to $ 2M and net income went from -$ 77M to -$ 3M. Revenue increased in 2 of those 5 years; net income in 3.
Cyclerion Therapeutics Inc currently holds a 5-year HDB Score of 5.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.92 | — |
1 Year2025-08-12 | $ 2.40 | 63.33% |
5 Years2021-08-12 | $ 65.60 | -94.02% |
All Time2019-04-02 | $ 289.80 | -98.65% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-04-02 |
|---|---|---|---|---|
| Price | $ 3.92 | $ 2.40 | $ 65.60 | $ 289.80 |
| Return | — | 63.33% | -94.02% | -98.65% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1M | -$ 6M | $ 1M |
| 2025 | $ 2M | -$ 3M | $ 3M |
| 2024 | $ 2M | -$ 3M | $ 3M |
| 2023 | $ 0.00 | -$ 5M | $ 7M |
| 2022 | $ 297K | -$ 44M | $ 13M |
| 2021 | $ 3M | -$ 51M | $ 53M |
| 2020 | $ 2M | -$ 77M | $ 54M |
| IPO2019 | $ 4M | -$ 123M | $ 97M |
Explore beyond CYCN
You're looking at Cyclerion Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
